192 related articles for article (PubMed ID: 18387817)
21. Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone.
Varinska L; van Wijhe M; Belleri M; Mitola S; Perjesi P; Presta M; Koolwijk P; Ivanova L; Mojzis J
Eur J Pharmacol; 2012 Sep; 691(1-3):125-33. PubMed ID: 22721615
[TBL] [Abstract][Full Text] [Related]
22. Antiangiogenic phytochemicals and medicinal herbs.
Jeong SJ; Koh W; Lee EO; Lee HJ; Lee HJ; Bae H; Lü J; Kim SH
Phytother Res; 2011 Jan; 25(1):1-10. PubMed ID: 20564543
[TBL] [Abstract][Full Text] [Related]
23. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
Wilson PM; LaBonte MJ; Lenz HJ
Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
[TBL] [Abstract][Full Text] [Related]
24. [Research advancement of endogenous angiogenesis inhibitors].
Wu JX; Xu BL; Huang WL
Ai Zheng; 2005 Mar; 24(3):376-84. PubMed ID: 15757547
[TBL] [Abstract][Full Text] [Related]
25. Antiangiogenic effects of marine sponge derived compounds on cancer.
Senthilkumar K; Venkatesan J; Manivasagan P; Kim SK
Environ Toxicol Pharmacol; 2013 Nov; 36(3):1097-108. PubMed ID: 24148290
[TBL] [Abstract][Full Text] [Related]
26. Vascular protection by dietary polyphenols.
Stoclet JC; Chataigneau T; Ndiaye M; Oak MH; El Bedoui J; Chataigneau M; Schini-Kerth VB
Eur J Pharmacol; 2004 Oct; 500(1-3):299-313. PubMed ID: 15464042
[TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic agents and targets: A perspective.
Teicher BA
Biochem Pharmacol; 2011 Jan; 81(1):6-12. PubMed ID: 20920481
[TBL] [Abstract][Full Text] [Related]
28. [Advances in the study of mechanisms of the tumor angiogenesis inhibitors].
Xiao D; Ding J
Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):219-23. PubMed ID: 12532783
[TBL] [Abstract][Full Text] [Related]
29. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer.
Prasad S; Phromnoi K; Yadav VR; Chaturvedi MM; Aggarwal BB
Planta Med; 2010 Aug; 76(11):1044-63. PubMed ID: 20635307
[TBL] [Abstract][Full Text] [Related]
30. Antiangiogenic strategies, compounds, and early clinical results in breast cancer.
Morabito A; Sarmiento R; Bonginelli P; Gasparini G
Crit Rev Oncol Hematol; 2004 Feb; 49(2):91-107. PubMed ID: 15012971
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity and mode of action of four naturally occuring flavonoids from the genus Dorstenia: gancaonin Q, 4-hydroxylonchocarpin, 6-prenylapigenin, and 6,8-diprenyleriodictyol.
Kuete V; Ngameni B; Wiench B; Krusche B; Horwedel C; Ngadjui BT; Efferth T
Planta Med; 2011 Dec; 77(18):1984-9. PubMed ID: 21800276
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis inhibitors in cancer therapy.
Dredge K; Dalgleish AG; Marriott JB
Curr Opin Investig Drugs; 2003 Jun; 4(6):667-74. PubMed ID: 12901224
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Chalcones from Medicago sativa L. and Their Hypolipidemic and Antiangiogenic Activities.
Ma QG; Li T; Wei RR; Liu WM; Sang ZP; Song ZW
J Agric Food Chem; 2016 Nov; 64(43):8138-8145. PubMed ID: 27741571
[TBL] [Abstract][Full Text] [Related]
34. Antiangiogenic strategies in breast cancer management.
Giovannini M; Aldrighetti D; Zucchinelli P; Belli C; Villa E
Crit Rev Oncol Hematol; 2010 Oct; 76(1):13-35. PubMed ID: 20702105
[TBL] [Abstract][Full Text] [Related]
35. Angiogenesis and antiangiogenic therapy in hematologic malignancies.
Dong X; Han ZC; Yang R
Crit Rev Oncol Hematol; 2007 May; 62(2):105-18. PubMed ID: 17188504
[TBL] [Abstract][Full Text] [Related]
36. Synopsis of angiogenesis inhibitors in oncology.
Ellis LM; Liu W; Fan F; Jung YD; Reinmuth N; Stoeltzing O; Takeda A; Akagi M; Parikh AA; Ahmad S
Oncology (Williston Park); 2002 May; 16(5 Suppl 4):14-22. PubMed ID: 12102576
[TBL] [Abstract][Full Text] [Related]
37. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
[TBL] [Abstract][Full Text] [Related]
38. Grape seed proanthocyanidins inhibit angiogenesis via the downregulation of both vascular endothelial growth factor and angiopoietin signaling.
Huang S; Yang N; Liu Y; Hu L; Zhao J; Gao J; Li Y; Li C; Zhang X; Huang T
Nutr Res; 2012 Jul; 32(7):530-6. PubMed ID: 22901561
[TBL] [Abstract][Full Text] [Related]
39. Flavonoids inhibit angiogenic cytokine production by human glioma cells.
Freitas S; Costa S; Azevedo C; Carvalho G; Freire S; Barbosa P; Velozo E; Schaer R; Tardy M; Meyer R; Nascimento I
Phytother Res; 2011 Jun; 25(6):916-21. PubMed ID: 21170924
[TBL] [Abstract][Full Text] [Related]
40. Tumor vasculature as target for therapeutic intervention.
Fens MH; Storm G; Schiffelers RM
Expert Opin Investig Drugs; 2010 Nov; 19(11):1321-38. PubMed ID: 20946091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
